The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

CR Holroyd, R Seth, M Bukhari, A Malaviya… - …, 2019 - academic.oup.com
Christopher R. Holroyd1, Rakhi Seth1, Marwan Bukhari2, Anshuman Malaviya3, Claire
Holmes1, Elizabeth Curtis4, Christopher Chan1, Mohammed A. Yusuf3, Anna Litwic4, 5 …

[HTML][HTML] Macrophage phenotypes and hepatitis B virus infection

Y Li, S Li, X Duan, C Yang, M Xu… - Journal of Clinical and …, 2020 - ncbi.nlm.nih.gov
Globally, hepatitis B virus (HBV) infection and its related liver diseases account for 780,000
deaths every year. Outcomes of HBV infection depend on the interaction between the virus …

Low frequency of opportunistic infections in patients receiving vedolizumab in clinical trials and post-marketing setting

SC Ng, IN Hilmi, A Blake, F Bhayat… - Inflammatory Bowel …, 2018 - academic.oup.com
Background Vedolizumab (ENTYVIO) is a humanized α4β7 integrin antagonist approved for
the treatment of inflammatory bowel disease, which selectively blocks gut-specific …

[HTML][HTML] Hepatobiliary manifestations in inflammatory bowel disease: A practical approach

P Núñez, F Castro, G Mezzano, R Quera… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Inflammatory bowel diseases (IBD) are associated with various hepatobiliary disorders.
They can occur at any moment in the course of the disease or associated with the treatment …

Size matters! Anti-HBs titer and HBV reactivation during anti-TNF therapy

S Poola, MK Kratzer, K Sewell, HL Tillmann - Digestive Diseases and …, 2023 - Springer
Abstract Background and Aims We and others have previously described that hepatitis B
surface antibody (anti-HBs) seems to protect against clinically significant HBV reactivation in …

Incidence of malignancies in a cohort of psoriatic arthritis patients taking traditional disease modifying antirheumatic drug and tumor necrosis factor inhibitor therapy …

L Costa, F Caso, A Del Puente, MND Di Minno… - The Journal of …, 2016 - jrheum.org
Objective. Psoriatic arthritis (PsA) is an inflammatory arthropathy, associated with skin and/or
nail psoriasis. As suggested in 2012 by the Group for Research and Assessment of …

[HTML][HTML] Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity

AH Solay, A Acar, F Eser, F Kuşcu… - The Turkish Journal …, 2018 - ncbi.nlm.nih.gov
Materials and Methods Patients who were followed up for the use of biological agents in our
clinic were evaluated retrospectively. Patients with isolated anti-HBc IgG positivity were …

Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis

M Sebastiani, L Milazzo, F Atzeni, C Vacchi… - Modern …, 2019 - academic.oup.com
Objectives: The recent introduction of direct-acting antiviral agents (DAAs) which can
eliminate Hepatitis C virus (HCV) had revolutionized the treatment of HCV infections also in …

[HTML][HTML] Macrophage polarization in viral infectious diseases: Confrontation with the reality

P Abou Atmeh, S Mezouar, JL Mège - … -Celebrating 140 Years of …, 2022 - intechopen.com
The role of macrophages in viral infections is well documented. Their activation status also
called macrophage polarization categorized by the dichotomy of M1 and M2 phenotype …

The Saudi consensus recommendations for the management of psoriatic arthritis (2023)

IA Al-Homood, N Al Ghanim, MIA Fatani… - Clinical …, 2024 - Springer
Psoriatic arthritis (PsA) is a complex inflammatory disease characterized by musculoskeletal
and non-musculoskeletal manifestations. It is a distinct disease entity at the interface …